HLA-DQB1, major histocompatibility complex, class II, DQ beta 1, 3119
N. diseases: 504; N. variants: 43
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.827 | 0.320 | 6 | 32659937 | 3 prime UTR variant | T/G | snv | 0.56 |
|
Eye Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 6 | 32664881 | missense variant | A/T | snv | 3.2E-05 |
|
Eye Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.925 | 0.080 | 6 | 32664882 | missense variant | C/G;T | snv | 3.9E-02 |
|
Eye Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.851 | 0.160 | 6 | 32666690 | 5 prime UTR variant | C/T | snv | 0.20 |
|
Immune System Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.925 | 0.120 | 6 | 32660651 | non coding transcript exon variant | C/A | snv | 9.6E-02 |
|
0.700 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
1.000 | 0.080 | 6 | 32659314 | upstream gene variant | A/G | snv | 2.9E-02 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.827 | 0.320 | 6 | 32659937 | 3 prime UTR variant | T/G | snv | 0.56 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
1.000 | 0.080 | 6 | 32665110 | intron variant | C/A;T | snv |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.925 | 0.120 | 6 | 32660651 | non coding transcript exon variant | C/A | snv | 9.6E-02 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.080 | 6 | 32659473 | 3 prime UTR variant | C/A | snv | 0.51 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.080 | 6 | 32668608 | upstream gene variant | A/G;T | snv |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.851 | 0.160 | 6 | 32666690 | 5 prime UTR variant | C/T | snv | 0.20 |
|
Digestive System Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.851 | 0.160 | 6 | 32666690 | 5 prime UTR variant | C/T | snv | 0.20 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
6 | 32665113 | intron variant | C/A;G | snv | 1.5E-05 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
6 | 32659175 | upstream gene variant | T/A;C | snv |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||||||
|
6 | 32661139 | intron variant | G/A | snv | 1.8E-02 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
0.925 | 0.120 | 6 | 32665055 | missense variant | A/C;T | snv | 0.77 |
|
Digestive System Diseases; Chemically-Induced Disorders | 0.800 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1.000 | 0.040 | 6 | 32664181 | non coding transcript exon variant | C/A;G;T | snv | 1.7E-03 |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.080 | 6 | 32664882 | missense variant | C/G;T | snv | 3.9E-02 |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 6 | 32668587 | upstream gene variant | G/A | snv | 0.37 |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.851 | 0.160 | 6 | 32666690 | 5 prime UTR variant | C/T | snv | 0.20 |
|
Digestive System Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.040 | 6 | 32659383 | upstream gene variant | A/G | snv | 0.56 |
|
Respiratory Tract Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.827 | 0.320 | 6 | 32659937 | 3 prime UTR variant | T/G | snv | 0.56 |
|
Digestive System Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.925 | 0.120 | 6 | 32661407 | missense variant | A/G | snv |
|
Endocrine System Diseases | 0.010 | 1.000 | 1 | 2000 | 2000 | ||||||||
|
0.925 | 0.120 | 6 | 32661407 | missense variant | A/G | snv |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2000 | 2000 |